Virtual Reality to Reduce Pre-procedure Anxiety Prior ECT
PERFECT-VR
Virtual Reality as a Tool to Reduce Pre-procedure Anxiety Prior ECT Via Enhancing Patient Education
1 other identifier
interventional
64
1 country
1
Brief Summary
Lack of patient knowledge about ECT (electroconvulsive therapy) is a leading cause of treatment fear with 60% of ECT patients reporting high levels of anxiety. The purpose of this study is to determine if using Virtual Reality (VR) to allow patients' to experience a virtual ECT education session before treatment is useful in lowering treatment anxiety and increasing knowledge about ECT if compared to standard treatment. In addition, measuring heart rate and blood pressure levels before ECT treatment will allow us to assess changes in anxiety levels. Individuals who choose to participate will be placed (participant will have a 50% chance to be placed in either group) to view either a virtual reality video to experience a virtual ECT session, or to receive standard preparation, i.e. a discussion with a psychiatrist. Before and after this session participants will be asked to complete a measurement of their anxiety level and knowledge about ECT (ECT Attitude \& Knowledge Questionnaire). Just before ECT treatment, blood pressure, heart rate and anxiety level will be measured. Participants will also complete cognitive and depression assessments. This study will help to develop a relationship between healthcare providers and patients and their families to help with education before ECT treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2020
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 12, 2019
CompletedFirst Posted
Study publicly available on registry
March 2, 2020
CompletedStudy Start
First participant enrolled
November 27, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
March 16, 2026
March 1, 2026
5.5 years
November 12, 2019
March 12, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Change in Pre-operative Anxiety
Change in pre-operative anxiety will be assessed using the Visual Anxiety Scale (VAS, Not at all anxious to extremely anxious).
Measurement completed 1) up to 2-3 days before ECT education 2) right after ECT education 3) prior to ECT (day of proceudre)
Change in ECT Knowledge
Change in ECT knowledge will be assessed using the ECT Attitude \& Knowledge Questionnaire.
Measurement completed 1) Immediately Before ECT education 2) Immediately After ECT education 3) Immediately Prior to ECT
Heart rate
Heart rate will be measured in beats/min
Measurement completed prior to ECT session on the day of procedure.
Mean arterial blood pressure
Mean arterial blood pressure will be measured in mmHg.
Measurement completed prior to ECT session on the day of procedure.
Secondary Outcomes (3)
Cognitive Performance
Measurement completed 1) Before intervention on the day of procedure 2) Prior to ECT on the day of procedure
Depression
Measurement completed 1) Before intervention on the day of procedure 2) Prior to ECT on the day of procedure
Ease of Use of VR Technology
Measurement completed immediately after ECT education on the day of procedure.
Study Arms (2)
Immersive Virtual Reality
EXPERIMENTALPatients will be immersed in the ECT experience using VR-ECT 360o video (VR-ECT).
Standard Treatment
OTHERPatients will receive standard preparation for their ECT session.
Interventions
Patients in the VR arm will be immersed in the ECT process in first person utilizing Google Cardboard headsets. Patients will experience in 360 entering the procedure room, IV insertion, pretreatment checks, anesthetic induction followed by induction of seizure, and recovery. The experience will also have voice-over narration simultaneously describing the procedure and its risks and benefits.
Patients will receive preparation for their ECT as per standard of care, i.e. a discussion with a Psychiatrist.
Eligibility Criteria
You may qualify if:
- Age ≥18
- First time undergoing ECT within the last year
- Outpatient/inpatient recommended for ECT
- Within 2-4 days of ECT procedure or no ECT within the past year
- Referred by psychiatrist
- Able to understand English
- Able to watch and respond to questions
You may not qualify if:
- Lack of patient consent or capacity to give consent
- Visual and hearing impairments precluding the ability to watch or listen to video
- History of significant motion sickness (i.e. occur during exposure to physical, visual and virtual motion, cybersickness verbally declared by patient)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sunnybrook Health Sciences Centre
Toronto, Ontario, M4N 3M5, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Fahad Alam
SHSC
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2019
First Posted
March 2, 2020
Study Start
November 27, 2020
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
June 1, 2026
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share